MedMen Enterprises (XCNQ:MMEN) Earnings Yield (Joel Greenblatt) % : 149.25% (As of Mar. 2023)

View and export this data going back to 1987. Start your Free Trial

What is MedMen Enterprises Earnings Yield (Joel Greenblatt) %?

MedMen Enterprises's Enterprise Value for the quarter that ended in Mar. 2023 was C$-120.4 Mil. MedMen Enterprises's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 was C$-178.5 Mil. MedMen Enterprises's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2023 was 149.25%.

The historical rank and industry rank for MedMen Enterprises's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

XCNQ:MMEN's Earnings Yield (Joel Greenblatt) % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 2.36
* Ranked among companies with meaningful Earnings Yield (Joel Greenblatt) % only.

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. MedMen Enterprises's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2023 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.

MedMen Enterprises Earnings Yield (Joel Greenblatt) % Historical Data

The historical data trend for MedMen Enterprises's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMen Enterprises Earnings Yield (Joel Greenblatt) % Chart

MedMen Enterprises Annual Data

Trend

Oct13

Oct14

Oct15

Oct16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Earnings Yield (Joel Greenblatt) %

Get a 7-Day Free Trial

-0.04

-37.45

-175.44

-46.30

2,000.00

MedMen Enterprises Quarterly Data
	Apr18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Earnings Yield (Joel Greenblatt) %	Get a 7-Day Free Trial															-42.55	2,000.00	161.29	114.94	149.25

Competitive Comparison of MedMen Enterprises's Earnings Yield (Joel Greenblatt) %

For the Drug Manufacturers - Specialty & Generic subindustry, MedMen Enterprises's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MedMen Enterprises's Earnings Yield (Joel Greenblatt) % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MedMen Enterprises's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where MedMen Enterprises's Earnings Yield (Joel Greenblatt) % falls into.

MedMen Enterprises Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

MedMen Enterprisess Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Jun. 2022 is calculated as

Earnings Yield (Joel Greenblatt)	=	EBIT	/	Enterprise Value
	=	-169.497	/	-8.5824
	=	1,974.94 %

MedMen Enterprises's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-178.5 Mil.

MedMen Enterprises (XCNQ:MMEN) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.

Be Aware

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.

MedMen Enterprises Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of MedMen Enterprises's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.

MedMen Enterprises (XCNQ:MMEN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MedMen Enterprises Inc (XCNQ:MMEN) » Definitions » Earnings Yield (Joel Greenblatt) %

Comparable Companies

Traded in Other Exchanges

N/A

Address

10115 Jefferson Boulevard, Culver City, CA, USA, 90232

Website

https://www.medmen.com

MedMen Enterprises Inc formerly known as Ladera Ventures Corp is the preeminent cannabis company with multiple assets and operations in California, Nevada, and New York, which combined account for nearly half of North America's addressable legal market. The company owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail.

MedMen Enterprises (XCNQ:MMEN) Headlines

No Headlines